Clinical characteristics of renal cell carcinoma in Korean patients with von Hippel-Lindau disease compared to sporadic bilateral or multifocal renal cell carcinoma

Journal of Korean Medical Science

Volumn 24, Issue 6, 2009, Pages 1145-1149

  Kim, Won Tae ^a,b   Ham, Won Sik ^a   Ju, Hee Jeong ^a   Lee, Jin Sun ^a   Lee, Jin Sung ^a   Choi, Young Deuk ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

Author keywords

Carcinoma; Incidence; Renal cell; Von Hippel Lindau disease

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; SURVIVAL RATE; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; ADULT; AGED; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; VON HIPPEL-LINDAU DISEASE; YOUNG ADULT;

EID: 75349100778     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.6.1145     Document Type: Article

References (21)

1. Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH. von Hippel-Lindau disease. Lancet 2003; 361: 2059-67.
2. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L. Identification of the von Hippel-Lindau disease tumour suppressor gene. Science 1993; 260: 1317-20.
3. Maher ER, Iselius L, Yates JR, Littler M, Benjamin C, Harris R, Sampson J, Williams A, Ferguson-Smith MA, Morton N. Von Hippel-Lindau disease: a genetic study. J Med Genet 1991; 28: 443-7.
4. Kim DS, Kim JJ, Yoon DK, Koh SK, Won NH. A case of von Hippel-Lindau disease diagnosed by initial symptoms of urologic manifestation. Korean J Urol 1987; 28: 126-32.
5. Kang IS, Lee YI, Seo IY, Jeong HJ, Rim JS. Renal cell carcinoma associated with von Hippel-Lindau disease treated by wedge resection. Korean J Urol 2004; 45: 495-7.
6. Kim JH, Cheon SH, Oh CS, Kim YM, Park RJ. Cystic renal cell carcinoma associated with von Hippel-Lindau disease treated by nephron sparing surgery. Korean J Urol 2005; 46: 93-5.
7. Klein B, Weirich G, Brauch H. DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations. Hum Genet 2001; 108: 376-84.
8. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G, Hsia YE, Lamiell J, Li H, Wei MH, Schmidt L, Tory K, Kuzmin I, Stackhouse T, Latif F, Linehan WM, Lerman M, Zbar B. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 1995; 5: 66-75.
9. Richards FM, Webster AR, McMahon R. Woodward ER, Rose S, Maher ER. Molecular genetic analysis of von Hippel-Lindau disease. J Intern Med 1998; 243: 527-33.
10. Rocha JC, Silva RL, Mendonca BB, Marui S, Simpson AJ, Camargo AA. High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil. J Med Genet 2003; 40: e31.
11. Neumann HP, Wiestler OD. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet 1991; 337: 1052-4.
12. Maddock IR, Moran A, Maher ER, Teare MD, Norman A, Payne SJ, Whitehouse R, Dodd C, Lavin M, Hartley N, Super M, Evans DG. A genetic register for von Hippel-Lindau disease. J Med Genet 1996; 33: 120-7.
13. Friedrich CA. Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer 1999; 86 (Suppl 2): 2478-82.
14. Richard S, Campello C, Taillandier L, Parker F, Resche F. Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL study Group. J Intern Med 1998; 243: 547-53.
15. Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA. Clinical features and natural history of von Hippel-Lindau disease. Q J Med 1990; 77: 1151-63.
16. Hes FJ, Slootweg PJ, van Vroonhoven TJ, Hene RJ, Feldberg MA, Zewald RA, Ploos van Amstel JK, Hoppener JW, Pearson PL, Lips CJ. Management of renal cell carcinoma in von Hippel-Lindau disease. Eur J Clin Invest 1999; 29: 68-75.
17. Neumann HP, Bender BU, Berger DP, Laubenberger J, Schultze-seemann W, Wetterauer U, Ferstl FJ, Herbst EW, Schwarzkopf G, Hes FJ, Lips CJ, Lamiell JM, Masek O, Riegler P, Mueller B, Glavac D, Brauch H. Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol 1998; 160: 1248-54.
18. Ishikawa I, Kovacs G. High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology 1993; 22: 135-9.
19. Steinbach F, Novick AC, Zincke H, Miller DP, Williams RD, Lund G, Skinner DG, Esriq D, Richie JP, deKernion JB, Marshall F, Marsh CL. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol 1995; 153: 1812-6.
20. Walther MM, Choyke PL, Weiss G, Manolatos C, Long J, Reiter R, Alexander RB, Linehan WM. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma. J Urol 1995; 153: 913-6.
21. Ploussard G, Droupy S, Ferlicot S, Ples R, Rocher L, Richard S, Benoit G. Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease. Urology 2007; 70: 435-9.